XPH
XPH
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 AXSM | Axsome Therapeutics, Inc. | 2.11% | 29.05K | $4.65M |
 OGN | Organon & Co. | 2.10% | 603.99K | $4.64M |
 MNMD | Mind Medicine (MindMed) Inc. | 2.09% | 350.29K | $4.61M |
 MBX | MBX Biosciences, Inc. Common Stock | 2.08% | 150.47K | $4.59M |
 NUVB | Nuvation Bio Inc. | 2.08% | 553.14K | $4.59M |
 LLY | Eli Lilly and Company | 2.06% | 4.37K | $4.54M |
 MRK | Merck & Co., Inc. | 2.05% | 44.42K | $4.53M |
 SUPN | Supernus Pharmaceuticals, Inc. | 2.05% | 93.95K | $4.52M |
 CRNX | Crinetics Pharmaceuticals, Inc. | 2.05% | 90.23K | $4.52M |
 BMY | Bristol-Myers Squibb Company | 2.04% | 84.68K | $4.51M |
 LGND | Ligand Pharmaceuticals Incorporated | 2.00% | 23.57K | $4.42M |
 AMRX | Amneal Pharmaceuticals, Inc. | 2.00% | 355.17K | $4.42M |
 RPRX | Royalty Pharma plc | 1.99% | 113.35K | $4.40M |
 PRGO | Perrigo Company plc | 1.99% | 320.76K | $4.39M |
 VTRS | Viatris Inc. | 1.98% | 373.85K | $4.37M |
 ELAN | Elanco Animal Health Incorporated | 1.98% | 203.60K | $4.36M |
 PHAT | Phathom Pharmaceuticals, Inc. | 1.97% | 256.97K | $4.36M |
 ZTS | Zoetis Inc. | 1.96% | 36.73K | $4.33M |
 EWTX | Edgewise Therapeutics, Inc. | 1.91% | 182.67K | $4.23M |
 XERS | Xeris Biopharma Holdings, Inc. | 1.91% | 624.87K | $4.23M |
SECTOR HOLDINGS
Healthcare
TechnologyASSET ALLOCATION BY REGION
United States
Ireland
Canada
Singapore
Cayman IslandsSECTOR HOLDINGS
Healthcare TechnologyASSET ALLOCATION BY REGION
United States Ireland Canada Singapore Cayman IslandsHoldings (Top 20)
AXSM
Axsome Therapeutics, Inc.
OGN
Organon & Co.
MNMD
Mind Medicine (MindMed) Inc.
MBX
MBX Biosciences, Inc. Common Stock
NUVB
Nuvation Bio Inc.
LLY
Eli Lilly and Company
MRK
Merck & Co., Inc.
SUPN
Supernus Pharmaceuticals, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
BMY
Bristol-Myers Squibb Company
LGND
Ligand Pharmaceuticals Incorporated
AMRX
Amneal Pharmaceuticals, Inc.
RPRX
Royalty Pharma plc
PRGO
Perrigo Company plc
VTRS
Viatris Inc.
ELAN
Elanco Animal Health Incorporated
PHAT
Phathom Pharmaceuticals, Inc.
ZTS
Zoetis Inc.
EWTX
Edgewise Therapeutics, Inc.
XERS
Xeris Biopharma Holdings, Inc.